Epoetin kappa biosimilar (JCR Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin kappa biosimilar (JCR Pharmaceuticals)
Drug Alias NameEpoetin alfa生物Epoetin Alfa BS Injection [JCR]Epoetin alfa生物类似药Epoetin alfa biosimilar (JCR Pharmaceuticals/Kissei Pharmaceuticals)Epoetin alfa biosimilar 1 +[9] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2010/01/20
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJcr Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJcr Pharmaceuticals Co LtdKissei Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksKEGG